Canada Pension Plan Investment Board
VKTX icon

Canada Pension Plan Investment Board’s Viking Therapeutics VKTX Stock Holding History

Canada Pension Plan Investment Board’s Portfolio VKTX Stock Details VKTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.03M Buy
26,500
+8,200
+45% +$265K ﹤0.01% 1018
2026
Q1 		$595K Buy
18,300
+11,800
+182% +$379K ﹤0.01% 1181
2025
Q4 		$229K Buy
+6,500
New +$230K ﹤0.01% 1613

Other funds holding VKTX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

Canada Pension Plan Investment Board's VKTX Position: Q2 2026 in Review

Canada Pension Plan Investment Board increased its Viking Therapeutics (VKTX) stake by 45% in Q2 2026, buying an estimated $265K and bringing the position to 26,500 shares worth $1.03M. The position accounts for ﹤0.01% of the portfolio, ranked #1018.

Canada Pension Plan Investment Board first reported a position in VKTX in Q4 2025 and has held it in 3 quarters since. 436 funds tracked by Wall St. Rank hold VKTX as of Q2 2026.

  • Canada Pension Plan Investment Board held 26,500 shares of Viking Therapeutics worth $1.03M as of Q2 2026.
  • Canada Pension Plan Investment Board bought 8,200 Viking Therapeutics shares in Q2 2026, an estimated $265K.
  • Viking Therapeutics made up ﹤0.01% of Canada Pension Plan Investment Board's portfolio in Q2 2026, its #1018 holding.
  • Canada Pension Plan Investment Board first reported a position in Viking Therapeutics in Q4 2025 and has held it in 3 quarters since.
  • 436 funds tracked by Wall St. Rank held Viking Therapeutics as of Q2 2026.

Based on Canada Pension Plan Investment Board's 13F filing for Q2 2026, filed 14 Aug 2026.